Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Venneri

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|June 6, 2024
Response rates to second-line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib-based regimeJoshua Bomsztyk, Sriram Ravichandran, Jahanzaib Khwaja, et al.
European Journal of Heart Failure|June 26, 2024
Expansion of the National Amyloidosis Centre staging system to detect early mortality in transthyretin cardiac amyloidosisChristian Nitsche, Adam Ioannou, Rishi K Patel, et al.
Journal of the American College of Cardiology|May 13, 2024
Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac AmyloidosisAdam Ioannou, Carlo Fumagalli, Yousuf Razvi, et al.
JACC. Cardiovascular Imaging|January 17, 2023
Multi-Imaging Characterization of Cardiac Phenotype in Different Types of AmyloidosisAdam Ioannou, Rishi K Patel, Yousuf Razvi, et al.
European Journal of Heart Failure|November 24, 2023
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importanceAdam Ioannou, Muhammad U Rauf, Rishi K Patel, et al.
JAMA Cardiology|March 6, 2024
Cardiopulmonary Exercise Testing in Evaluating Transthyretin AmyloidosisRishi K Patel, Francesco Bandera, Lucia Venneri, et al.
European Journal of Heart Failure|October 18, 2024
Microvascular obstruction in cardiac amyloidosisLucrezia Netti, Adam Ioannou, Ana Martinez-Naharro, et al.
Journal of the American Heart Association|February 5, 2024
Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac AmyloidosisAdam Ioannou, Christian Nitsche, Aldostefano Porcari, et al.
European Journal of Heart Failure|January 16, 2023
Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathyAldostefano Porcari, Yousuf Razvi, Ambra Masi, et al.
JACC. Cardiooncology|April 17, 2025
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac AmyloidosisCarlo Fumagalli, Adam Ioannou, Francesco Cappelli, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|June 6, 2024
Response rates to second-line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib-based regimeJoshua Bomsztyk, Sriram Ravichandran, Jahanzaib Khwaja, et al.
European Journal of Heart Failure|June 26, 2024
Expansion of the National Amyloidosis Centre staging system to detect early mortality in transthyretin cardiac amyloidosisChristian Nitsche, Adam Ioannou, Rishi K Patel, et al.
Journal of the American College of Cardiology|May 13, 2024
Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac AmyloidosisAdam Ioannou, Carlo Fumagalli, Yousuf Razvi, et al.
JACC. Cardiovascular Imaging|January 17, 2023
Multi-Imaging Characterization of Cardiac Phenotype in Different Types of AmyloidosisAdam Ioannou, Rishi K Patel, Yousuf Razvi, et al.
European Journal of Heart Failure|November 24, 2023
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importanceAdam Ioannou, Muhammad U Rauf, Rishi K Patel, et al.
JAMA Cardiology|March 6, 2024
Cardiopulmonary Exercise Testing in Evaluating Transthyretin AmyloidosisRishi K Patel, Francesco Bandera, Lucia Venneri, et al.
European Journal of Heart Failure|October 18, 2024
Microvascular obstruction in cardiac amyloidosisLucrezia Netti, Adam Ioannou, Ana Martinez-Naharro, et al.
Journal of the American Heart Association|February 5, 2024
Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac AmyloidosisAdam Ioannou, Christian Nitsche, Aldostefano Porcari, et al.
European Journal of Heart Failure|January 16, 2023
Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathyAldostefano Porcari, Yousuf Razvi, Ambra Masi, et al.
JACC. Cardiooncology|April 17, 2025
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac AmyloidosisCarlo Fumagalli, Adam Ioannou, Francesco Cappelli, et al.
Pageof 7